Background: Exacerbation is one of the most significant problems in patients with asthma. Although subpopulation of patients is more susceptible to exacerbations than others, which clinical features characterise susceptibility to exacerbation are not well understood. Methods: Consecutive non-smoking adult patients with asthma who had multiple exacerbations (ME) despite regular maintenance treatment were compared with those who had at most single exacerbation as control during the previous 1 year. Exacerbation of asthma is defined initiations or escalations of systemic corticosteroid as part of the management for aggravated asthma condition. Results: Patients with ME (n = 32, mate: 6, mean age: 46.7 years) were characterised by intensive current maintenance treatment (dose of inhaled corticosteroid; 1037.5 +/- 452.8 vs 621.6 +/- 257.3 mu g, P = 0.0005, proportion of oral corticosteroid users; 28.1% vs 2.7%, P = 0.008), severe episodes of exacerbation (asthma-related hospitalisations; 71.9% vs 23.4%, P = 0.0002, arrival on ambulance; 37.5% vs 8.1%, P = 0.008), concomitant chronic sinusitis (34.4% vs 10.8%, P = 0.038) and intolerance to non-steroidal anti-inflammatory drugs (NSAIDs) (34.4% vs 5.4%, P = 0.006) in comparison with controls (n = 37, male:11, mean age:44.4). Pulmonary function in patients with ME was characterised by persistent airflow limitation and reduced reversibility. Conclusion: Patients with ME are at increased risk for severe exacerbation despite more intensive maintenance anti-inflammatory treatment. Persistent irreversible airflow limitation and complications of chronic sinusitis and/or NSAIDs intolerance are characteristics to this subpopulation. (c) 2005 Elsevier Ltd. All rights reserved.
机构:
Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
Harvard Univ, Sch Med, Boston, MA USAMassachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
Hasegawa, Kohei
Sullivan, Ashley
论文数: 0引用数: 0
h-index: 0
机构:
Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USAMassachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
Sullivan, Ashley
Turner, Stuart
论文数: 0引用数: 0
h-index: 0
机构:
Novartis Pharmaceut, E Hanover, NJ USAMassachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
Turner, Stuart
Massaro, Susan
论文数: 0引用数: 0
h-index: 0
机构:
Novartis Pharmaceut, E Hanover, NJ USAMassachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
Massaro, Susan
Camargo, Carlos, Jr.
论文数: 0引用数: 0
h-index: 0
机构:
Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
Harvard Univ, Sch Med, Boston, MA USAMassachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA
机构:
AstraZeneca, Res & Early Dev, Resp & Immunol, Clin, Cambridge, EnglandAstraZeneca, Res & Early Dev, Resp & Immunol, Clin, Cambridge, England
Hughes, Rod
Rapsomaniki, Eleni
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca, Real World Data Sci, BioPharmaceut Med, Cambridge, EnglandAstraZeneca, Res & Early Dev, Resp & Immunol, Clin, Cambridge, England
Rapsomaniki, Eleni
论文数: 引用数:
h-index:
机构:
Janson, Christer
Keen, Christina
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca, Res & Early Dev, Resp & Immunol, Clin,BioPharmaceut R&D, Gothenburg, SwedenAstraZeneca, Res & Early Dev, Resp & Immunol, Clin, Cambridge, England
Keen, Christina
Make, Barry J.
论文数: 0引用数: 0
h-index: 0
机构:
Natl Jewish Hlth, Denver, CO USA
Univ Colorado Denver, Denver, CO USAAstraZeneca, Res & Early Dev, Resp & Immunol, Clin, Cambridge, England
Make, Barry J.
Burgel, Pierre-Regis
论文数: 0引用数: 0
h-index: 0
机构:
Cochin Hosp, Assistance Publ Hop Paris, Dept Resp Med, Paris, France
Univ Paris, Inst Cochin, Inserm U1016, Paris, FranceAstraZeneca, Res & Early Dev, Resp & Immunol, Clin, Cambridge, England
Burgel, Pierre-Regis
Tomaszewski, Erin L.
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca, Patient Centered Sci, BioPharmaceut Med, Gaithersburg, MD USAAstraZeneca, Res & Early Dev, Resp & Immunol, Clin, Cambridge, England
Tomaszewski, Erin L.
Mullerova, Hana
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca, Resp & Immunol, Med & Payer Evidence, BioPharmaceut Med, Cambridge, EnglandAstraZeneca, Res & Early Dev, Resp & Immunol, Clin, Cambridge, England
Mullerova, Hana
Reddel, Helen K.
论文数: 0引用数: 0
h-index: 0
机构:
Woolcock Inst Med Res, Sydney, NSW, Australia
Univ Sydney, Sydney, NSW, AustraliaAstraZeneca, Res & Early Dev, Resp & Immunol, Clin, Cambridge, England
机构:
Keio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, Japan
Natl Hosp Org Tokyo Med Ctr, Dept Resp Med, Tokyo, Japan
Natl Hosp Org Tokyo Med Ctr, Dept Allergy, Tokyo, JapanKeio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, Japan
Mochimaru, Takao
Chubachi, Shotaro
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, JapanKeio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, Japan
Chubachi, Shotaro
论文数: 引用数:
h-index:
机构:
Irie, Hidehiro
Sakurai, Kaori
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, JapanKeio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, Japan
Sakurai, Kaori
Okuzumi, Shinichi
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, JapanKeio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, Japan
Okuzumi, Shinichi
Sunata, Keeya
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, JapanKeio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, Japan
Sunata, Keeya
论文数: 引用数:
h-index:
机构:
Masaki, Katsunori
Miyata, Jun
论文数: 0引用数: 0
h-index: 0
机构:
Natl Def Med Coll, Div Infect Dis & Resp Med, Dept Internal Med, Saitama, JapanKeio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, Japan
Miyata, Jun
Nakamura, Hidetoshi
论文数: 0引用数: 0
h-index: 0
机构:
Saitama Med Univ Hosp, Div Pulm Med, Saitama, JapanKeio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, Japan
Nakamura, Hidetoshi
Asano, Koichiro
论文数: 0引用数: 0
h-index: 0
机构:
Tokai Univ, Div Pulm Med, Dept Med, Sch Med, Hiratsuka, Kanagawa, JapanKeio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, Japan
Asano, Koichiro
Fukunaga, Koichi
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, JapanKeio Univ, Div Pulm Med, Dept Med, Sch Med, Tokyo, Japan